NCT07192484Not yet recruiting
Effects of Kinesio Taping in Subacute Stroke Patients
Effects of Kinesio Taping on Gait Ability, Balance, and Neuromuscular Functions in Subacute Stroke Patients With Foot Drop
Source: ClinicalTrials.gov · Last updated 25 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A study was designed to investigate the effects of KT on gait ability, balance, and neuromuscular functions in subacute stroke patients with foot drop. The study aims to evaluate the immediate and short-term effects of KT on gait ability, balance, and neuromuscular function in subacute stroke patients with foot drop. A total of 60 participants will be recruited and randomly assigned to either a control group (conventional physical therapy) or an experimental group (receiving additional KT). Both groups will receive 30 minutes of daily physical therapy. The experimental group will undergo an initial assessment before KT application, which includes (1) activation of the dorsiflexor muscles, (2) reduction of plantar flexor spasticity, and (3) stabilization of the ankle in an everted position. After taping, a second assessment will be conducted immediately, and the tape will stay applied to patient's limb for two days, followed by a third assessment. The control group will be assessed only before the intervention and after two days. Primary outcome measures include gait ability (10-meter walk test, laboratory gait parameters, and joint angles and electromyographic activity during walking). Secondary outcomes include balance (Functional reach test, Timed Up and Go test, and Activities-specific Balance Confidence Scale) and neuromuscular function assessments (muscle strength, joint range of motion, spasticity, and proprioception). This project aims to establish and validate a clinically applicable and effective KT protocol as an adjunctive gait training method for subacute stroke patients with foot drop. By enhancing independent and safe walking, this intervention may facilitate the early return to normal daily activities for stroke survivors.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 4 Sept 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Fooyin University
- Diseases
- Stroke
- NCT number
- NCT07192484
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 15 Sept 2025 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other neurological disorders or unstable medical conditions;
- Skin allergies that interfere with the use of tape;
- Cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score \< 24;
- Pusher syndrome;
- Poorly controlled hypertension or cardiovascular disease;
- Any other disease, apart from stroke, that may affect balance or gait.
Other
- Visual field defects;
- Ankle contracture;
- Hemispatial neglect;
Who the study is looking for
- Age between 20 and 80 years;
- First unilateral stroke;
- Stroke onset between at least 1 week and 1 year;
- Ability to continuously walk 10 meters with or without assistive devices;
- Presence of foot drop on the affected side during the swing phase due to insufficient ankle dorsiflexion;
- Brunnstrom stage of the affected lower limb ≥ 3;
- Presence of mild spasticity in the affected ankle plantar flexors, with a Modified Ashworth Scale score ≤ 2;
- Ability to follow simple commands
Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.